Rights and permissions
About this article
Cite this article
Ranibizumab cost effective for AMD in Greece. Pharmacoecon. Outcomes News 647, 7 (2012). https://doi.org/10.2165/00151234-201206470-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206470-00020